Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2002, p. 1993-1995, Vol. 46, No. 6
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.6.1993-1995.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
F. Hoffman-La Roche, Nutley, New Jersey,1 Roche Global Development, Welwyn,,2 GlaxoSmithKline, Brentford, Middlesex, United Kingdom3
Received 15 October 2001/ Returned for modification 4 January 2002/ Accepted 11 March 2002
Twelve volunteers completed a two-sequence, three-way crossover study of a single 900-mg aspirin dose and multiple doses of 75 mg of oseltamivir in the absence and presence of 900 mg of aspirin. The plasma and urine results demonstrated no pharmacokinetic interaction between oseltamivir and aspirin.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»